Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Clinical Evidence
Download this slideset discussing the latest evidence and guideline recommendations for use of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists in patients with type 2 diabetes and obesity.
Professor of Medicine and Pharmacology Assistant Dean for Clinical Research Tullis Tulane Alumni Chair in Diabetes Chief, Section of Endocrinology Tulane University Health Sciences center New Orleans, Louisiana
Jennifer B. Green, MD
Professor of Medicine Division of Endocrinology Department of Medicine Duke Clinical Research Institute Duke University Medical Center Durham, North Carolina
Carol Hatch Wysham, MD
Clinical Professor of Medicine Clinical Endocrinologist MultiCare/Rockwood Clinic Spokane, Washington
Provided by Clinical Care Options, LLC in partnership with Endocrine Society.
Supported by an educational grant from Lilly.
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.